US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.378
  • -0.002-0.59%
15min DelayClose May 14 16:00 ET
2.59MMarket Cap-56P/E (TTM)

Agile Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
73.36%-9.58M
111.03%172K
102.19%365K
-190.35%-8.52M
89.19%-1.6M
44.87%-35.95M
90.62%-1.56M
10.10%-16.7M
80.87%-2.93M
-0.57%-14.75M
Net income from continuing operations
43.08%-14.47M
-13.71%-4.47M
86.54%-798K
26.34%-3.81M
48.10%-5.39M
64.24%-25.41M
79.87%-3.93M
64.66%-5.93M
70.70%-5.17M
39.37%-10.39M
Operating gains losses
53.05%-6.76M
103.88%130K
-35.00%-3.53M
76.26%-1.67M
-21.89%-1.69M
-276.22%-14.4M
---3.35M
---2.61M
---7.05M
---1.38M
Depreciation and amortization
-74.84%386K
9.89%100K
-62.60%98K
-83.98%95K
-84.18%93K
-30.99%1.53M
-84.17%91K
-52.54%262K
7.82%593K
7.69%588K
Other non cash items
-46.01%1.06M
-32.63%225K
-69.93%252K
-26.19%279K
-26.73%307K
18.54%1.97M
-16.29%334K
110.55%838K
-11.48%378K
-4.12%419K
Change In working capital
393.16%7.42M
-35.47%2.82M
139.84%3.9M
-150.92%-3.89M
196.44%4.58M
11.32%-2.53M
341.47%4.38M
-93.62%-9.8M
1,489.40%7.65M
-746.67%-4.75M
-Change in receivables
99.19%-15K
-61.38%129K
157.88%940K
-131.46%-1.34M
105.28%254K
-176.05%-1.84M
249.11%334K
-1,043.66%-1.62M
603.31%4.25M
-985.27%-4.81M
-Change in inventory
-189.25%-2.21M
-1,758.82%-1.13M
-76.98%125K
-192.07%-325K
49.10%-879K
87.87%-763K
104.81%68K
138.43%543K
118.86%353K
-8.62%-1.73M
-Change in prepaid assets
157.95%2.27M
-108.64%-210K
121.54%607K
188.04%1.61M
-63.22%260K
191.00%880K
3,064.63%2.43M
-96.10%-2.82M
327.48%560K
67.93%707K
-Change in payables and accrued expense
1,324.20%7.69M
159.68%4.12M
139.48%2.31M
-247.80%-3.77M
359.00%5.03M
-112.07%-628K
-42.15%1.59M
-188.19%-5.86M
-17.83%2.55M
-21.39%1.1M
-Change in other current liabilities
-82.29%-319K
-95.35%-84K
-92.86%-81K
-11.59%-77K
-266.67%-77K
-33.59%-175K
-48.28%-43K
-16.67%-42K
-102.94%-69K
34.38%-21K
Cash from discontinued investing activities
Operating cash flow
73.36%-9.58M
111.03%172K
102.19%365K
-190.35%-8.52M
89.19%-1.6M
44.87%-35.95M
90.62%-1.56M
10.10%-16.7M
80.87%-2.93M
-0.57%-14.75M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
-100.34%-133K
0
0
-100.04%-7K
-100.78%-126K
Net PPE purchase and sale
--0
--0
--0
--0
--0
50.56%-133K
--0
--0
91.03%-7K
-77.46%-126K
Net investment purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
-100.34%-133K
--0
--0
-100.04%-7K
-100.78%-126K
Financing cash flow
Cash flow from continuing financing activities
-68.95%6.89M
-173.79%-487K
-102.83%-278K
-43.76%6.88M
248.76%778K
-27.08%22.18M
-96.87%660K
334.17%9.82M
85.37%12.23M
-208.06%-523K
Net issuance payments of debt
92.25%-1.35M
-116.89%-488K
97.14%-348K
---286K
95.50%-225K
---17.38M
---225K
---12.15M
--0
---5M
Net common stock issuance
-76.76%8.24M
-99.89%1K
-99.68%70K
-41.42%7.16M
188.22%1M
16.75%35.43M
-95.80%886K
871.31%21.97M
85.37%12.23M
-14.91%348K
Net preferred stock issuance
--0
--0
--0
--0
--0
--4.13M
---1K
--0
--0
--4.13M
Proceeds from stock option exercised by employees
--0
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-68.95%6.89M
-173.79%-487K
-102.83%-278K
-43.76%6.88M
248.76%778K
-27.08%22.18M
-96.87%660K
334.17%9.82M
85.37%12.23M
-208.06%-523K
Net cash flow
Beginning cash position
-72.60%5.25M
-53.25%2.87M
-78.62%2.79M
18.33%4.43M
-72.60%5.25M
32.36%19.14M
-58.30%6.15M
-50.12%13.03M
-77.27%3.74M
32.36%19.14M
Current changes in cash
80.65%-2.69M
64.85%-316K
101.28%88K
-117.71%-1.64M
94.69%-817K
-396.94%-13.9M
-120.39%-899K
39.54%-6.88M
-3.83%9.28M
-869.62%-15.4M
End cash Position
-51.26%2.56M
-51.26%2.56M
-53.25%2.87M
-78.62%2.79M
18.33%4.43M
-72.60%5.25M
-72.60%5.25M
-58.30%6.15M
-50.12%13.03M
-77.27%3.74M
Free cash flow
73.46%-9.58M
111.03%172K
102.19%365K
-189.66%-8.52M
89.28%-1.6M
44.89%-36.08M
90.65%-1.56M
10.42%-16.7M
80.92%-2.94M
-0.94%-14.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 73.36%-9.58M111.03%172K102.19%365K-190.35%-8.52M89.19%-1.6M44.87%-35.95M90.62%-1.56M10.10%-16.7M80.87%-2.93M-0.57%-14.75M
Net income from continuing operations 43.08%-14.47M-13.71%-4.47M86.54%-798K26.34%-3.81M48.10%-5.39M64.24%-25.41M79.87%-3.93M64.66%-5.93M70.70%-5.17M39.37%-10.39M
Operating gains losses 53.05%-6.76M103.88%130K-35.00%-3.53M76.26%-1.67M-21.89%-1.69M-276.22%-14.4M---3.35M---2.61M---7.05M---1.38M
Depreciation and amortization -74.84%386K9.89%100K-62.60%98K-83.98%95K-84.18%93K-30.99%1.53M-84.17%91K-52.54%262K7.82%593K7.69%588K
Other non cash items -46.01%1.06M-32.63%225K-69.93%252K-26.19%279K-26.73%307K18.54%1.97M-16.29%334K110.55%838K-11.48%378K-4.12%419K
Change In working capital 393.16%7.42M-35.47%2.82M139.84%3.9M-150.92%-3.89M196.44%4.58M11.32%-2.53M341.47%4.38M-93.62%-9.8M1,489.40%7.65M-746.67%-4.75M
-Change in receivables 99.19%-15K-61.38%129K157.88%940K-131.46%-1.34M105.28%254K-176.05%-1.84M249.11%334K-1,043.66%-1.62M603.31%4.25M-985.27%-4.81M
-Change in inventory -189.25%-2.21M-1,758.82%-1.13M-76.98%125K-192.07%-325K49.10%-879K87.87%-763K104.81%68K138.43%543K118.86%353K-8.62%-1.73M
-Change in prepaid assets 157.95%2.27M-108.64%-210K121.54%607K188.04%1.61M-63.22%260K191.00%880K3,064.63%2.43M-96.10%-2.82M327.48%560K67.93%707K
-Change in payables and accrued expense 1,324.20%7.69M159.68%4.12M139.48%2.31M-247.80%-3.77M359.00%5.03M-112.07%-628K-42.15%1.59M-188.19%-5.86M-17.83%2.55M-21.39%1.1M
-Change in other current liabilities -82.29%-319K-95.35%-84K-92.86%-81K-11.59%-77K-266.67%-77K-33.59%-175K-48.28%-43K-16.67%-42K-102.94%-69K34.38%-21K
Cash from discontinued investing activities
Operating cash flow 73.36%-9.58M111.03%172K102.19%365K-190.35%-8.52M89.19%-1.6M44.87%-35.95M90.62%-1.56M10.10%-16.7M80.87%-2.93M-0.57%-14.75M
Investing cash flow
Cash flow from continuing investing activities 00000-100.34%-133K00-100.04%-7K-100.78%-126K
Net PPE purchase and sale --0--0--0--0--050.56%-133K--0--091.03%-7K-77.46%-126K
Net investment purchase and sale --0------------------0----------------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0-100.34%-133K--0--0-100.04%-7K-100.78%-126K
Financing cash flow
Cash flow from continuing financing activities -68.95%6.89M-173.79%-487K-102.83%-278K-43.76%6.88M248.76%778K-27.08%22.18M-96.87%660K334.17%9.82M85.37%12.23M-208.06%-523K
Net issuance payments of debt 92.25%-1.35M-116.89%-488K97.14%-348K---286K95.50%-225K---17.38M---225K---12.15M--0---5M
Net common stock issuance -76.76%8.24M-99.89%1K-99.68%70K-41.42%7.16M188.22%1M16.75%35.43M-95.80%886K871.31%21.97M85.37%12.23M-14.91%348K
Net preferred stock issuance --0--0--0--0--0--4.13M---1K--0--0--4.13M
Proceeds from stock option exercised by employees --0------------------0----------------
Cash from discontinued financing activities
Financing cash flow -68.95%6.89M-173.79%-487K-102.83%-278K-43.76%6.88M248.76%778K-27.08%22.18M-96.87%660K334.17%9.82M85.37%12.23M-208.06%-523K
Net cash flow
Beginning cash position -72.60%5.25M-53.25%2.87M-78.62%2.79M18.33%4.43M-72.60%5.25M32.36%19.14M-58.30%6.15M-50.12%13.03M-77.27%3.74M32.36%19.14M
Current changes in cash 80.65%-2.69M64.85%-316K101.28%88K-117.71%-1.64M94.69%-817K-396.94%-13.9M-120.39%-899K39.54%-6.88M-3.83%9.28M-869.62%-15.4M
End cash Position -51.26%2.56M-51.26%2.56M-53.25%2.87M-78.62%2.79M18.33%4.43M-72.60%5.25M-72.60%5.25M-58.30%6.15M-50.12%13.03M-77.27%3.74M
Free cash flow 73.46%-9.58M111.03%172K102.19%365K-189.66%-8.52M89.28%-1.6M44.89%-36.08M90.65%-1.56M10.42%-16.7M80.92%-2.94M-0.94%-14.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg